Successful treatment with daratumumab, lenalidomide, and dexamethasone therapy followed by autologous stem cell transplantation for newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome: a case report

Successful treatment with daratumumab, lenalidomide, and dexamethasone therapy followed by autologous stem cell transplantation for newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome: a case report

Abstract Background Transplant-eligible patients with polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome are treated with induction therapy and autologous stem cell transplantation. Conventional induction therapies may exacerbate neuropathy and a high rate of disease prog...

Full description

Bibliographic Details
Main Authors: Ryutaro Taenaka, Sakurako Shimokawa, Ayako Katayama, Toshihiko Nagao, Teppei Obara, Naoaki Nishimura, Atsushi Tsujimoto, Kentaro Kohno, Kenichi Aoki, Ryosuke Ogawa
Format: Article
Language:English
Published: BMC 2022-08-01
Series:Journal of Medical Case Reports
Subjects:
POEMS syndrome
DLd therapy
Autologous stem cell transplantation
Daratumumab
Lenalidomide
Online Access:https://doi.org/10.1186/s13256-022-03552-y

Internet

https://doi.org/10.1186/s13256-022-03552-y

Similar Items